M1713 The Relationship Between Bacterial Overgrowth, Intestinal Permeability and TNF Alpha in Pediatric Short Bowel Syndrome

2008 ◽  
Vol 134 (4) ◽  
pp. A-403
Author(s):  
Conrad R. Cole ◽  
Juliana C. Frem ◽  
Andrew T. Gewirtz ◽  
Benjamin D. Gold ◽  
Thomas R. Ziegler
Author(s):  
Javier Bueno ◽  
Laura García-Martínez ◽  
Susana Redecillas ◽  
Oscar Segarra ◽  
Manuel López

Abstract Background The Serial Transverse Enteroplasty Procedure (STEP) Registry has reported a 47% success to achieve enteral autonomy in pediatric short bowel syndrome (SBS). We have performed the STEP with a technical modification (MSTEP) consisting in stapler application without mesenteric defects that can also be applied to the duodenum. Our experience with this technique is described. Materials and Methods In this study, 16 children with SBS underwent MSTEP (2005–2019). Indications were nutritional autonomy achievement (n = 11, with duodenal lengthening in 5/11) and bacterial overgrowth treatment (n = 5). Results With a median follow-up of 5.8 years (0.7–13.7 years), 5 of 11 (45%) patients achieved enteral autonomy, 4 of them with duodenal lengthening. Four of four who preserved > 50% colon, while only one of seven with < 50% of colon achieved enteral autonomy (p < 0.05). After redo procedures, three of four attained enteral autonomy. Thus, 8 of 11 (73%) progressed to enteral autonomy, including all with duodenal lengthening. One child, already parenteral nutrition free, died due to central line sepsis. All the patients from the bacterial translocation group improved their metabolic/nutritional status, but one required subsequent enterectomy of the lengthened intestine due to multiple ulcers in the staple lines. Conclusion The effectiveness of MSTEP to achieve enteral autonomy seems similar to the classical STEP. It can be applied to the duodenum. The retained colon length may influence the post-STEP enteral autonomy achievement.


2012 ◽  
Vol 7 (1) ◽  
pp. 130
Author(s):  
M. Chiba ◽  
Y. Sanada ◽  
T. Kanno ◽  
H. Yagi ◽  
C. Sato ◽  
...  

2019 ◽  
pp. 817-825 ◽  
Author(s):  
A. CINKAJZLOVÁ ◽  
Z. LACINOVÁ ◽  
J. KLOUČKOVÁ ◽  
P. KAVÁLKOVÁ ◽  
H. KRATOCHVÍLOVÁ ◽  
...  

The aim of our study was to assess the presence and degree of intestinal leakage in subjects suffering from short bowel syndrome (SBS) and its modification by parenteral nutrition. To this end we assessed circulating levels of selected makers of intestinal permeability including zonulin, fatty acid binding protein 2 (FABP-2), citrulline and glucagon-like peptide 2 (GLP-2). We also measured lipopolysaccharide binding protein (LBP) as a marker of circulating levels of lipopolysaccharide acting through the CD14 molecule. Eleven SBS and 10 age- and BMI-matched control subjects were included into the study. The effect of parenteral nutrition was assessed after 14 days, 6 and 12 months from its initiation, respectively. At baseline, SBS patients had increased gut permeability as measured by zonulin (47.24±2.14 vs. 39.48±1.20 ng/ml, p=0.006) and LBP (30.32±13.25 vs. 9.77±0.71 µg/ml, p<0.001) compared to healthy controls. Furthermore, SBS subjects had reduced FABP-2, unchanged citrulline and increased sCD14 and GLP-2 relative to control group. Throughout the whole study period the administered parenteral nutrition had no significant effect on any of the studied parameters. Taken together, our data show that patients with short bowel syndrome have increased intestinal permeability that is not affected by parenteral nutrition.


1997 ◽  
Vol 131 (3) ◽  
pp. 356-361 ◽  
Author(s):  
Stuart S. Kaufman ◽  
Candace A. Loseke ◽  
James V. Lupo ◽  
Rosemary J. Young ◽  
Nancy D. Murray ◽  
...  

2016 ◽  
Vol 40 (8) ◽  
pp. 1087-1087 ◽  
Author(s):  
Massimo Montalto ◽  
Gian Ludovico Rapaccini

Sign in / Sign up

Export Citation Format

Share Document